CPhI Pharma Awards finalists 2017
Crystec are delighted to be announced as finalists for the CPhI Excellence in Pharma Awards 2017, in both the ‘Formulation’ and ‘Contract Services and Outsourcing’ categories.
Crystec are delighted to have been announced as finalists in two categories of the CPhI Pharma Awards 2017. The two categories that Crystec have been shortlisted in include, Formulation (“Overcoming the formulation challenges of developing inhalable therapies using Crystec’s mSAS technology”), as well as Contract Services and Outsourcing (“Modified supercritical anti-solvent (mSAS) technology for accelerated product development”). A full list of finalists can be found at http://awards.cphi.com/finalists/, and the winners will be announced on Tuesday 24th October during the Awards gala at CPhI in Frankfurt.
For more information about Crystec’s modified supercritical anti-solvent (mSAS) technology or to book at meeting during CPhI in Frankfurt, please contact Emily Bevis (firstname.lastname@example.org).